D. E. Shaw & Co., Inc. Organon & Co. Put Options Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$13.78 - $18.8 $2.76 Million - $3.76 Million	-200,000 Reduced 83.89%	38,400 $721,000
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $2.61 Million - $4.13 Million	238,400 New	238,400 $3.44 Million
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $674,450 - $862,050	35,000 New	35,000 $728,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $28,670 - $37,130	-1,000 Reduced 1.82%	53,850 $1.64 Million
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $1.09 Million - $1.35 Million	-38,000 Reduced 40.93%	54,850 $1.8 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $2.64 Million - $3.53 Million	92,850 New	92,850 $2.81 Million

790

204M

1.71M

870K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.